Perceived Risk of Severe Respiratory Syncytial Virus Disease and Immunoprophylaxis Use Among US Pediatric Specialists.

about

The Logistics and Coordination of Respiratory Syncytial Virus Immunoprophylaxis Use Among US Pediatric Specialists.Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.

P2860

Q35888993-A34B3E7B-86EF-4D7C-A15A-1BCB05C829CD Q36295566-F5B1EF23-7985-457C-859E-CE853C8DFA3C

P2860

Perceived Risk of Severe Respiratory Syncytial Virus Disease and Immunoprophylaxis Use Among US Pediatric Specialists.

Item

http://www.wikidata.org/entity/Q40508352

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Perceived Risk of Severe Respi ...... mong US Pediatric Specialists.

@en

type

Item

label

Perceived Risk of Severe Respi ...... mong US Pediatric Specialists.

@en

prefLabel

Perceived Risk of Severe Respi ...... mong US Pediatric Specialists.

@en

P1476

Perceived Risk of Severe Respi ...... mong US Pediatric Specialists.

@en

P2093

Daniel F Garcia

http://www.w3.org/2001/XMLSchema#string

Deborah M Friedman

http://www.w3.org/2001/XMLSchema#string

Iqra A Syed

http://www.w3.org/2001/XMLSchema#string

Kimmie K McLaurin

http://www.w3.org/2001/XMLSchema#string

Michael G Marcus

http://www.w3.org/2001/XMLSchema#string

Pierre C Wong

http://www.w3.org/2001/XMLSchema#string

Prabhu S Parimi

http://www.w3.org/2001/XMLSchema#string

Shelagh M Szabo

http://www.w3.org/2001/XMLSchema#string

Veena R Kumar

http://www.w3.org/2001/XMLSchema#string

William V La Via

http://www.w3.org/2001/XMLSchema#string

P2860

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.

Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Children with Down syndrome are high-risk for severe respiratory syncytial virus disease.

Compliance with RSV prophylaxis: Global physicians' perspectives.

Respiratory morbidity in adulthood after respiratory syncytial virus hospitalization in infancy.

Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study.

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.

Severe RSV disease in preterm infants born at 29 to 35 weeks' gestation in the United States.

P304

724-737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0009922815604598

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph B Domachowske

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282153296

http://www.w3.org/2001/XMLSchema#string

P698

26400767

http://www.w3.org/2001/XMLSchema#string

Perceived Risk of Severe Respiratory Syncytial Virus Disease and Immunoprophylaxis Use Among US Pediatric Specialists.

about

P2860

P2860

Perceived Risk of Severe Respiratory Syncytial Virus Disease and Immunoprophylaxis Use Among US Pediatric Specialists.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698